SEVERINO, GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 104.102
NA - Nord America 4.064
AS - Asia 496
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 108.669
Nazione #
IT - Italia 103.006
US - Stati Uniti d'America 4.049
CN - Cina 395
UA - Ucraina 313
SE - Svezia 273
DE - Germania 214
FI - Finlandia 122
GB - Regno Unito 109
IN - India 30
VN - Vietnam 29
FR - Francia 25
SG - Singapore 23
BE - Belgio 14
CA - Canada 13
IR - Iran 6
ES - Italia 5
RU - Federazione Russa 5
TR - Turchia 5
HK - Hong Kong 4
IE - Irlanda 4
NL - Olanda 4
ID - Indonesia 3
BR - Brasile 2
EU - Europa 2
GR - Grecia 2
MX - Messico 2
CH - Svizzera 1
IL - Israele 1
IS - Islanda 1
LI - Liechtenstein 1
MK - Macedonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
VE - Venezuela 1
Totale 108.669
Città #
Cagliari 102.717
Fairfield 534
Woodbridge 451
Chandler 409
Ashburn 256
Houston 252
Nyköping 233
Ann Arbor 230
Wilmington 215
Seattle 209
Jacksonville 171
Cambridge 170
Dearborn 135
New York 86
Boardman 77
Beijing 75
Helsinki 68
Nanjing 62
Boston 49
Shanghai 49
San Diego 42
Atlanta 33
Dong Ket 29
Shenyang 27
Guangzhou 25
Redwood City 23
Norwalk 22
Pune 22
Hebei 19
Mountain View 17
Nanchang 17
Jiaxing 16
London 15
Brussels 14
Milan 13
Sassari 13
Falls Church 12
Changsha 11
Tianjin 11
Auburn Hills 10
Hefei 10
Rome 10
San Francisco 10
San Mateo 10
Zhengzhou 10
Kunming 9
Redmond 9
Toronto 9
Olbia 8
Verona 8
Ningbo 7
Orange 7
Nürnberg 6
Fuzhou 5
Hangzhou 5
Jinan 5
Suni 5
Bologna 4
Dublin 4
Hounslow 4
Konya 4
Lucknow 4
Phoenix 4
Walnut 4
Acton 3
Ardabil 3
Augusta 3
Baotou 3
Detroit 3
Indiana 3
Leipzig 3
Los Angeles 3
Millbury 3
Monmouth Junction 3
Paris 3
Seriate 3
Shaoxing 3
Taizhou 3
Berlin 2
Bungay 2
Capoterra 2
Florence 2
Genoa 2
Groningen 2
Heraklion 2
Hong Kong 2
Kansas City 2
Kilburn 2
Leawood 2
Lissone 2
Madrid 2
New Bedfont 2
Qingdao 2
Rockville 2
Sassuolo 2
Sestu 2
Suelli 2
Tappahannock 2
Taranto 2
Treviso 2
Totale 107.086
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 3.973
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 2.835
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 2.757
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 2.579
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.553
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 2.548
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study 2.436
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 2.425
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 2.424
Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder. A genome-wide association study 2.342
Involvement of core clock genes in lithium response 2.283
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients 2.225
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study 2.211
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 2.176
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.158
Analysis of the influence of microRNAs in lithium response in bipolar disorder 2.153
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder 2.139
Pharmacogenomics of bipolar disorder 2.123
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder 2.079
null 1.980
Prediction of Lithium Response using Clinical Data 1.947
Association study in three different populations between the GPR88 gene and major psychoses 1.927
null 1.842
Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample 1.752
Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report 1.658
Variant GADL1 and response to lithium in bipolar I disorder 1.561
Doctors and researchers: integrating data for bipolar disorder studies 1.542
null 1.525
The international consortium on lithium genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment 1.521
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.458
null 1.449
null 1.424
Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine. 1.423
Positive Association Between REV-ERB Alpha Gene and Bipolar Disorder in a Sardinian Population 1.418
Admixture analysis of age at onset in bipolar disorder 1.414
null 1.414
A retrospective case series of bipolar patients with adjunctive carbamazepine in long-term lithium treatment: evaluation of the effectiveness 1.399
Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21? 1.286
Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia 1.251
Valutazione della risposta ai sali di litio in pazienti sardi affetti da disturbo bipolare = Evaluation of lithium treatment response in Sardinian bipolar patients 1.247
A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample 1.214
Dopaminergic and serotonergic genes in bipolar disorder: A case control study in a Sardinian population 1.188
null 1.161
null 1.100
Dopaminergic and Serotoninergic genes in Bipolar Disorder: a case-control study in a sardinian population 1.027
A48G polymorphism in the D1 receptor genes associated with bipolar I disorder 1.009
Haplotype association study between DRD1 gene and parasuicide in bipolar disorder: Analysis of two samples from Canada and Sardinia 1.003
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 957
Candidate Genes in Bipolar 1 Sradinian Patients : A case control Study 935
Prediction of lithium response using genomic data 921
No evidence of association between dopamine D3 receptor gene and bipolar affective disorder 911
null 908
Candidate Genes in Bipolar 1 Sardinian Patients : A case control Study 897
A48G polymorphism in the D1 receptor genes associated with bipolar I disorder in a Sardinian population 851
Carbamazepine augmentation in lithium refractory bipolar patients: a prospective study on long-term prophylactic effectiveness 836
Bipolar disorder in Sardinian population: Age at onset as an endophenotype? 834
null 795
Catechol-O-methyltransferase Val(158)Met polymorphism in schizophrenia: associations with cognitive and motor impairment 773
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 769
Genetic, demographic and archival study on a Sardinian village (Escalaplano) Italy 724
Abuse of “poppers” and hemolytic anemia in a young G6Pd-deficient male 634
COMT Val(158)Met and BDNF (CT)-T-270 polymorphisms in schizophrenia: a case-control study 614
Evidence of a susceptibility locus for bipolar disorder on chromosome 1p in the Sardinian population 578
null 567
Suicidal Behavior in Major Psychosis from Epidemiology to Molecular Genetics 567
null 556
Adverse drug reactions: role of pharmacogenomics 545
Characterisation of age and polarity at onset in bipolar disorder 541
Farmaci per il trattamento delle cefalee primitive e per il controllo del vomito 535
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 508
Pharmacogenomics: state of research and prospectives in clinical application 463
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients 449
La terapia preventiva del disturbo bipolare: oltre il meccanismo d’azione dei farmaci 388
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review 325
Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder 322
A gene expression and protomi study provide further evidence for the involvement of spermidine/spermine N(1)-acetyltransferase (SSAT1) in suicide and suggests new biological determinants of suicidal behavior in bipolar disorder patients 320
Investigating the role of leukocyte telomere length in treatment-resistant depression and in response to electroconvulsive therapy 304
Can network analysis shed light on predictors of lithium response in bipolar I disorder? 302
Genetic and Epigenetic Markers of Lithium Response 297
The diacylglycerol kinase eta gene and bipolar disorder: a replication study in a Sardinian sample 264
Association study in a Sardinian sample between Bipolar Disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system 260
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patiens 251
No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample 201
Investigating the phenotypic and genetic associations between personality traits and suicidal behavior across major mental health diagnoses 198
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 193
Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment 172
Age at Onset in Sardinian Bipolar I Patients: Evidence for Three Subgroups 171
The PDLIM5 gene and lithium prophylaxis: an association and gene expression analysis in Sardinian patients with bipolar disorder 127
Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors 125
Manic-depressive illness: an association study with the inositol polyphosphate 1-phosphatase and serotonin transporter genes 95
Association study between the phenotype migraine without aura-panic disorder and dopaminergic receptor genes 93
Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (Translational Psychiatry, (2021), 11, 1, (606), 10.1038/s41398-021-01702-2) 92
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach 84
Erratum: Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: Machine learning approach (The British Journal of Psychiatry (2022) (1–10) DOI: 10.1192/bjp.2022.28) 84
Pharmacogenomics of bipolar disorder 55
Totale 108.950
Categoria #
all - tutte 127.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.951


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019887 0 0 0 0 0 0 0 0 0 225 357 305
2019/202020.768 883 479 107 373 7.666 5.361 2.975 675 521 433 436 859
2020/202134.498 1.057 1.321 1.203 8.821 6.530 4.078 2.595 2.550 1.030 1.942 2.201 1.170
2021/20228.334 1.137 667 555 516 542 566 607 380 719 712 1.071 862
2022/202311.660 731 1.390 1.371 1.006 880 1.406 567 744 932 948 1.177 508
2023/20248.826 538 434 469 847 1.131 1.804 1.942 796 439 426 0 0
Totale 108.950